(Q51552231)

6 April 2018

title

Apolipoproteins A-I, A-II and B, lipoprotein(a) and the risk of ischaemic heart disease: the Caerphilly study. (English)

1 reference

6 April 2018

arteriosclerotic heart disease

1 reference

1 reference

Sweetnam PM

1

1 reference

6 April 2018

Bolton CH

2

1 reference

6 April 2018

Downs LG

3

1 reference

6 April 2018

Durrington PN

4

1 reference

6 April 2018

MacKness MI

5

1 reference

6 April 2018

Elwood PC

6

1 reference

6 April 2018

Yarnell JW

7

1 reference

6 April 2018

publication date

1 November 2000

1 reference

6 April 2018

European Journal of Clinical Investigation

published in

1 reference

6 April 2018

volume

30

1 reference

6 April 2018

issue

11

1 reference

6 April 2018

page(s)

947-956

1 reference

6 April 2018

Are apolipoproteins better discriminators than lipids for atherosclerosis?

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00725.X

The Tromsø Heart Study: Serum apolipoprotein Al concentration in relation to future coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00725.X

Serum fatty acids, apolipoproteins, selenium and vitamin antioxidants and the risk of death from coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00725.X

A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00725.X

Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Göttingen Risk Incidence and Prevalence Study (GRIPS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00725.X

Apolipoprotein A-I and B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Québec cardiovascular study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00725.X

An epidemiologic reassessment of lipoprotein(a) and atherothrombotic risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00725.X

Predictive value of electrophoretically detected lipoprotein(a) for coronary heart disease and cerebrovascular disease in a community-based cohort of 9936 men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00725.X

Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00725.X

Plasma triglyceride and high density lipoprotein cholesterol as predictors of ischaemic heart disease in British men. The Caerphilly and Speedwell Collaborative Heart Disease Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00725.X

A comparison of methods for the immunoassay of serum apolipoprotein B in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00725.X

Apolipoproteins (a), AI, and B and parental history in men with early onset ischaemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00725.X

A prospective study of lipoprotein(a) and the risk of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00725.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00725.X

The immediate effect of streptokinase on serum lipoprotein(a) concentration and the effect of myocardial infarction on serum lipoprotein(a), apolipoproteins A1 and B, lipids and C-reactive protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2000.00725.X

10.1046/J.1365-2362.2000.00725.X

21 January 2018

Identifiers

DOI

1 reference

6 April 2018

PubMed ID

11114956

1 reference

6 April 2018